Document is current
Any future updates will be listed below
-
Authors
Xu, Qingqing
Zhu, Feng
Song, Ping
Fang, Yuemin
Bai, Zhiqing
Cheng, Tao
-
Funding
Funding for this research was provided by:
2025 Shanghai Pharmaceutical Services Youth Innovation Project (SPAYXFW2025A04)
- License Information
-
More Information
Article History
Received: 29 May 2025
Accepted: 11 February 2026
First Online: 11 March 2026
Declarations
:
: This study was approved by the Ethical Committee of Ruijin Hospital, Shanghai Jiaotong University School of Medicine. Following Commercial HK-2 cells were obtained from Pricella Biotechnology Co., Ltd. The research meets national and international guidelines.
: Not applicable.
: The authors declare no competing interests.
